COVID-19 and myotonic dystrophy: Case reports and systematic review.

Journal of infection in developing countries(2023)

引用 2|浏览4
暂无评分
摘要
There is a high mortality rate in patients with both Steinert's disease and COVID-19. It highlights the importance of strengthening prevention strategies, especially vaccination. All SD with SARS-CoV-2 infection/COVID-19 patients should be identified early and treated to avoid complications. It is still unknown which treatment regimen is best to use in those patients. Studies on a greater number of patients are necessary to provide clinicians with further evidence.
更多
查看译文
关键词
COVID-19,SARS-CoV-2,Steinert’s disease,myotonic dystrophy,neurologic disorders
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要